You are here

Article Text

Article menu

Download PDFPDF

Epidemiology and outcomes
Predictors of incident proteinuria among patients with SLE
  1. Alí Duarte-García1,
  2. Erik Barr2,
  3. Laurence S Magder2 and
  4. Michelle Petri3
  1. 1Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA
  3. 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  1. Correspondence to Dr Michelle Petri; mpetri{at}jhmi.edu

Abstract

Objective To identify fixed and time-varying predictors of incident proteinuria.

Methods This analysis was based on patients who did not have a history of diabetes and who did not have a prior episode of renal involvement. We defined an incident case of proteinuria as two or more measures of urine protein to creatinine ratio (or 24-hour protein measure) greater than 0.5 in two visits separated by more than 30 days and less than 180 days. We estimated rates of incident proteinuria in subgroups of patients with lupus defined by time-invariant and time-varying predictors.

Results Among 895 patients included in the analysis, 840 (94%) were female, and 518 (58%) were Caucasian, 304 (34%) African-American, with mean age of 42 years at the start of follow-up. We observed 57 incident cases of proteinuria over a span of 4669 person-years of cohort follow-up. The overall rate of incident proteinuria was 12.2 per 1000 person-years. The rate was significantly lower among those of older age, and higher among those who were not Caucasian. In those with a very low C3 measure in a previous cohort visit, the rate was increased by a factor of 16.1 and in those with a very low C4 by 16.3. The rate among those prescribed hydroxychloroquine or ACE inhibitors/ARB was similar to those not on them.

Conclusions Older patients with SLE are at low risk for developing proteinuria. There was not strong evidence that hydroxychloroquine or angiotensin-converting-enzyme (ACE) inhibitor reduced the risk of proteinuria. The highest rates of incident proteinuria were among those with recent low complement.

  • Lupus Nephritis
  • Systemic Lupus Erythematosus
  • Epidemiology

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/lupus-2016-000200

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors AD-G, EB, LSM and MP contributed to the conception or design of the work, the acquisition, analysis, or interpretation of data for the work and drafting or revising the work critically for intellectual content.

    • Funding The Hopkins Lupus Cohort is supported by the National Institutes of Health AR43727 and AR69572 grants.

    • Competing interests None declared.

    • Ethics approval Johns Hopkins IRB.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data sharing statement No additional data are available.